IGM Biosciences (IGMS) Competitors $1.77 -0.06 (-3.28%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IGMS vs. MBX, CYRX, KMDA, PRTC, ATXS, ALLO, AKBA, CDXC, TERN, and ABVXShould you be buying IGM Biosciences stock or one of its competitors? The main competitors of IGM Biosciences include MBX Biosciences (MBX), Cryoport (CYRX), Kamada (KMDA), PureTech Health (PRTC), Astria Therapeutics (ATXS), Allogene Therapeutics (ALLO), Akebia Therapeutics (AKBA), ChromaDex (CDXC), Terns Pharmaceuticals (TERN), and ABIVAX Société Anonyme (ABVX). These companies are all part of the "pharmaceutical products" industry. IGM Biosciences vs. MBX Biosciences Cryoport Kamada PureTech Health Astria Therapeutics Allogene Therapeutics Akebia Therapeutics ChromaDex Terns Pharmaceuticals ABIVAX Société Anonyme MBX Biosciences (NYSE:MBX) and IGM Biosciences (NASDAQ:IGMS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, community ranking, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership. Is MBX or IGMS more profitable? MBX Biosciences has a net margin of 0.00% compared to IGM Biosciences' net margin of -7,534.03%. MBX Biosciences' return on equity of 0.00% beat IGM Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets MBX BiosciencesN/A N/A N/A IGM Biosciences -7,534.03%-155.42%-61.04% Do analysts recommend MBX or IGMS? MBX Biosciences currently has a consensus price target of $37.25, suggesting a potential upside of 276.64%. IGM Biosciences has a consensus price target of $5.50, suggesting a potential upside of 210.73%. Given MBX Biosciences' stronger consensus rating and higher possible upside, research analysts plainly believe MBX Biosciences is more favorable than IGM Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MBX Biosciences 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00IGM Biosciences 1 Sell rating(s) 9 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.90 Does the MarketBeat Community believe in MBX or IGMS? IGM Biosciences received 68 more outperform votes than MBX Biosciences when rated by MarketBeat users. However, 100.00% of users gave MBX Biosciences an outperform vote while only 47.68% of users gave IGM Biosciences an outperform vote. CompanyUnderperformOutperformMBX BiosciencesOutperform Votes4100.00% Underperform VotesNo VotesIGM BiosciencesOutperform Votes7247.68% Underperform Votes7952.32% Do institutionals and insiders believe in MBX or IGMS? 42.8% of IGM Biosciences shares are owned by institutional investors. 57.0% of IGM Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings and valuation, MBX or IGMS? MBX Biosciences has higher earnings, but lower revenue than IGM Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMBX BiosciencesN/AN/AN/AN/AN/AIGM Biosciences$2.13M49.41-$246.42M-$3.64-0.49 Does the media prefer MBX or IGMS? In the previous week, IGM Biosciences had 6 more articles in the media than MBX Biosciences. MarketBeat recorded 6 mentions for IGM Biosciences and 0 mentions for MBX Biosciences. IGM Biosciences' average media sentiment score of 0.04 beat MBX Biosciences' score of 0.00 indicating that IGM Biosciences is being referred to more favorably in the news media. Company Overall Sentiment MBX Biosciences Neutral IGM Biosciences Neutral SummaryMBX Biosciences beats IGM Biosciences on 7 of the 13 factors compared between the two stocks. Get IGM Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IGMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IGMS vs. The Competition Export to ExcelMetricIGM BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$105.24M$6.23B$5.21B$9.15BDividend YieldN/A2.94%5.13%4.03%P/E Ratio-0.499.4687.9017.36Price / Sales49.41310.131,245.5478.03Price / CashN/A61.4443.7535.97Price / Book0.516.055.314.79Net Income-$246.42M$154.90M$122.62M$225.00M7 Day PerformanceN/A-0.32%0.58%2.62%1 Month Performance-74.35%0.43%2.54%3.81%1 Year Performance-83.17%3.08%25.49%20.10% IGM Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IGMSIGM Biosciences4.6954 of 5 stars$1.77-3.3%$5.50+210.7%-83.2%$105.24M$2.13M-0.49190Gap UpMBXMBX BiosciencesN/A$12.71-7.2%$37.25+193.1%N/A$424.73MN/A0.0036Gap DownCYRXCryoport3.4168 of 5 stars$8.41-1.2%$12.29+46.1%-48.1%$415.71M$233.26M-2.491,170Analyst ForecastShort Interest ↓News CoverageKMDAKamada4.0001 of 5 stars$7.23-2.4%$14.50+100.6%+22.0%$415.58M$158.38M25.82360PRTCPureTech Health1.7364 of 5 stars$17.33-1.5%$45.00+159.7%-23.3%$414.92M$3.33M0.00100Gap DownHigh Trading VolumeATXSAstria Therapeutics1.4925 of 5 stars$7.34-1.5%$25.60+248.8%-3.0%$414.23MN/A-3.5130Positive NewsALLOAllogene Therapeutics2.6297 of 5 stars$1.95-5.3%$9.73+399.1%-41.1%$408.86M$43,000.00-1.25310AKBAAkebia Therapeutics3.9 of 5 stars$1.87+6.6%$7.50+302.1%+47.9%$406.91M$169.88M-8.11430Short Interest ↑Analyst RevisionPositive NewsCDXCChromaDex4.5806 of 5 stars$5.30+0.6%$8.00+50.9%+324.3%$404.83M$91.67M530.53120Short Interest ↑TERNTerns Pharmaceuticals3.8011 of 5 stars$4.74-5.4%$18.30+286.1%-8.8%$402.61M$1M-4.0240ABVXABIVAX Société Anonyme2.1457 of 5 stars$6.34-0.6%$38.67+509.9%-46.8%$401.63MN/A0.0061 Related Companies and Tools Related Companies MBX Alternatives CYRX Alternatives KMDA Alternatives PRTC Alternatives ATXS Alternatives ALLO Alternatives AKBA Alternatives CDXC Alternatives TERN Alternatives ABVX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IGMS) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGM Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IGMS Stock Alerts